Sarcio, Inc.
- Biotech or pharma, therapeutic R&D
Sarcio, Inc. is a regenerative medicine company that is developing a first-in-class regenerative exosome therapeutic for the treatment of osteoarthritis. Our lead product, SEV-101 is positioned to become the first Regenerative Exosome Therapeutic for Osteoarthritis with projected annual sales of ~$2B.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}